文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

X连锁低磷血症中附着点病的患病率:一项探索性超声研究。

Prevalence of enthesopathies in X-linked hypophosphatemia: an explorative ultrasound study.

作者信息

Bachfischer Lisa, Behanova Martina, Rath Eva, Meng Stefan, Mittelbach Andreas, Haschka Judith, Dechat Thomas, Raimann Adalbert, Mindler Gabriel, Uyanik Gökhan, Zwerina Jochen, Kocijan Roland

机构信息

Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK, 1140 Vienna, Austria.

1st Medical Department, Hanusch Hospital, 1140 Vienna, Austria.

出版信息

JBMR Plus. 2025 Jul 7;9(9):ziaf113. doi: 10.1093/jbmrpl/ziaf113. eCollection 2025 Sep.


DOI:10.1093/jbmrpl/ziaf113
PMID:40800666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12342808/
Abstract

X-linked hypophosphatemia (XLH) is a rare genetic disorder characterized by renal phosphate wasting, leading to rickets in children and osteomalacia in adults. An underrecognized symptom in adults with XLH is enthesopathy, leading to pain and reduced quality of life. Although enthesopathies primarily affect tendon insertions, they are closely linked to the underlying bone pathology of XLH, reflecting mineralization defects characteristic of osteomalacia. This study aimed to determine the prevalence of enthesopathies in XLH patients using ultrasound and assess their association with pain and physical function. This cross-sectional study included 26 XLH patients (mean age: 37.9 ± 17.1 yr, 76.9% female). Ultrasound examinations assessed 6 tendons of the upper and 10 tendons of the lower extremity in adolescents and adults with XLH. Laboratory tests included phosphate, alkaline phosphatase, and i-FGF23 levels. Physical performance was evaluated using the 6-min walk test (6MWT) and the chair rising test. Pain was assessed using the brief pain inventory. Enthesopathies were detected by ultrasound in 84.6% of patients, affecting predominantly the lower extremities (80.8%) but also the upper extremities (50%). The quadriceps and achilles tendons were the most frequently affected sites. Enthesopathy prevalence increased with age ( = 0.61,  < .05) and negatively correlated with 6MWT performance ( = -0.4,  = .04). No significant association was found between enthesopathies and BMI or pain scores. Based on the worst pain scale, 73.1% of patients reported mild pain. Inter-rater agreement for ultrasound assessment was good to very good/excellent. Enthesopathies of the lower, but also upper extremities are common features of XLH. Their presence correlates with reduced mobility, emphasizing the need for targeted interventions. The exact pathophysiological mechanisms remain unclear, but age appears to be a key factor.

摘要

X连锁低磷血症(XLH)是一种罕见的遗传性疾病,其特征为肾脏磷酸盐流失,导致儿童佝偻病和成人骨软化症。XLH成人患者中一种未得到充分认识的症状是附着点病,会导致疼痛并降低生活质量。虽然附着点病主要影响肌腱附着处,但它们与XLH的潜在骨骼病理密切相关,反映了骨软化症的矿化缺陷特征。本研究旨在使用超声确定XLH患者中附着点病的患病率,并评估其与疼痛和身体功能的关联。这项横断面研究纳入了26例XLH患者(平均年龄:37.9±17.1岁,76.9%为女性)。超声检查评估了青少年和成人XLH患者上肢的6条肌腱和下肢的10条肌腱。实验室检查包括磷酸盐、碱性磷酸酶和i-FGF23水平。使用6分钟步行试验(6MWT)和从椅子上起身试验评估身体表现。使用简明疼痛量表评估疼痛。超声检查发现84.6%的患者存在附着点病,主要影响下肢(80.8%),但也影响上肢(50%)。股四头肌和跟腱是最常受累的部位。附着点病的患病率随年龄增加而升高(r = 0.61,P <.05),并与6MWT表现呈负相关(r = -0.4,P = 0.04)。未发现附着点病与体重指数或疼痛评分之间存在显著关联。根据最严重疼痛量表,73.1%的患者报告有轻度疼痛。超声评估的评分者间一致性良好至非常好/优秀。下肢以及上肢的附着点病是XLH的常见特征。它们的存在与活动能力下降相关,强调了针对性干预的必要性。确切的病理生理机制尚不清楚,但年龄似乎是一个关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/c813e22d377e/ziaf113f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/8d58e1b6013a/ziaf113ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/5cd816cc2e26/ziaf113f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/51142dd634ee/ziaf113f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/ddd30d9dab99/ziaf113f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/c813e22d377e/ziaf113f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/8d58e1b6013a/ziaf113ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/5cd816cc2e26/ziaf113f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/51142dd634ee/ziaf113f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/ddd30d9dab99/ziaf113f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afaa/12342808/c813e22d377e/ziaf113f4.jpg

相似文献

[1]
Prevalence of enthesopathies in X-linked hypophosphatemia: an explorative ultrasound study.

JBMR Plus. 2025-7-7

[2]
X-Linked Hypophosphatemia

1993

[3]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[4]
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults With X-Linked Hypophosphatemia.

J Bone Miner Res. 2025-5-2

[5]
3D-DXA reveals significant effects of burosumab on trabecular and cortical skeletal envelopes in symptomatic adults with X-linked Hypophosphatemia.

J Bone Miner Res. 2025-7-13

[6]
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.

J Bone Miner Res. 2024-9-26

[7]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[8]
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.

Cochrane Database Syst Rev. 2016-3-31

[9]
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience.

J Clin Endocrinol Metab. 2025-6-17

[10]
Ultrasound and shockwave therapy for acute fractures in adults.

Cochrane Database Syst Rev. 2023-3-3

本文引用的文献

[1]
18F-Sodium Fluoride PET/CT as a Tool to Assess Enthesopathies in X-Linked Hypophosphatemia.

Calcif Tissue Int. 2025-1-26

[2]
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Nat Rev Nephrol. 2025-5

[3]
Midfoot and Forefoot Disorders in Adolescents and Adults with X-Linked Hypophosphatemia.

J Clin Med. 2024-11-9

[4]
Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.

JCI Insight. 2023-9-8

[5]
The ankle in XLH: Reduced motion, power and quality of life.

Front Endocrinol (Lausanne). 2023

[6]
Impact of X-Linked Hypophosphatemia on Muscle Symptoms.

Genes (Basel). 2022-12-19

[7]
The Enthesopathy of XLH Is a Mechanical Adaptation to Osteomalacia: Biomechanical Evidence from Hyp Mice.

Calcif Tissue Int. 2022-9

[8]
Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia.

Front Endocrinol (Lausanne). 2021

[9]
Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data.

J Clin Endocrinol Metab. 2022-2-17

[10]
Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors.

J Clin Endocrinol Metab. 2022-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索